Gerardo Vázquez-Gómez

Dr. Gerardo Vázquez-Gómez

Institute of Biophysics of the Czech Academy of Sciences, 612 65, Brno, Czech Republic
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2018 in Toxicology Letters
Verified
Journal Article
Closed access
Gerardo Vázquez-GómezGerardo Vázquez-Gómez
Gerardo Vázquez-Gómez
LRL. Rocha-Zavaleta
L. Rocha-Zavaleta
Miriam Rodriguez-SosaMiriam Rodriguez-Sosa
Miriam Rodriguez-Sosa
PPP. Petrosyan
P. Petrosyan
JRJ. Rubio-Lightbourn
J. Rubio-Lightbourn

22 June 2018 in Toxicological Sciences
Verified
Journal Article
Closed access
PDF file
MHMartina Hýžd′Alová
Martina Hýžd′Alová
JPJakub Pivnička
Jakub Pivnička
OZOndřej Zapletal
Ondřej Zapletal
Gerardo Vázquez-GómezGerardo Vázquez-Gómez
Gerardo Vázquez-Gómez
JMJason Matthews
Jason Matthews
JVJan Vondracek
Jan Vondracek
Polycyclic aromatic hydrocarbons (PAHs) are widespread environmental contaminants that interact in a complex manner with both the aryl hydrocarbon receptor (AhR) and estrogen receptors (ER). Their potential endocrine-disrupting activities may depend on both inhibitory AhR-ER cross-talk and on AhR-dependent metabolic production of estrogenic PAH metabolites. Here, we analyzed the impact of AhR on estrogen-like effects of PAHs, such as benzo[a]pyrene (BaP), in particular, on control of cell cycle progression/cell proliferation. Using AhR knockout variant of estrogen-sensitive human breast cancer MCF-7 cells (MCF-7 AhR KO cells), we observed that the AhR-dependent control of cytochrome P450 family 1 (CYP1) expression played a major role in formation of estrogenic BaP metabolites, most notably 3-OH-BaP, which contributed to the ER-dependent induction of cell cycle progression/cell proliferation. Both BaP metabolism and the BaP-induced S-phase transition/cell proliferation were inhibited in MCF-7 AhR KO cells, whereas these cells remained sensitive towards both endogenous estrogen 17β-estradiol or hydroxylated BaP metabolites. BaP was found to increase the activity of ER-dependent luciferase reporter gene in wild-type MCF-7 cells; however, unlike its hydroxylated metabolite, BaP failed to stimulate luciferase activity in MCF-7 AhR KO cells. Similarly, estrogen-like effects of other known estrogenic PAHs, such as benz[a]anthracene or 3-methylcholanthrene, were diminished in MCF-7 AhR KO cells. Ectopic expression of human CYP1A1 and CYP1B1 enzymes partly restored both BaP metabolism and its effects on cell proliferation. Taken together, our data suggest that the AhR-dependent metabolism of PAHs contributes significantly to the impact of PAHs on cell proliferation in estrogen-sensitive cells.

17 February 2022 in Cells
Verified
Journal Article
Open access
PDF file
Gerardo Vázquez-GómezGerardo Vázquez-Gómez
Gerardo Vázquez-Gómez
MKMartina Karasová
Martina Karasová
ZTZuzana Tylichová
Zuzana Tylichová
MKMarkéta Kabátková
Markéta Kabátková
AHAleš Hampl
Aleš Hampl
JVJan Vondracek
Jan Vondracek
Apart from its role in the metabolism of carcinogens, the aryl hydrocarbon receptor (AhR) has been suggested to be involved in the control of inflammatory responses within the respiratory tract. However, the mechanisms responsible for this are only partially known. In this study, we used A549 cell line, as a human model of lung alveolar type II (ATII)-like cells, to study the functional role of the AhR in control of inflammatory responses. Using IL-1β as an inflammation inducer, we found that the induction of cyclooxygenase-2 and secretion of prostaglandins, as well as expression and release of pro-inflammatory cytokines, were significantly higher in the AhR-deficient A549 cells. This was linked with an increased nuclear factor-κB (NF-κB) activity, and significantly enhanced phosphorylation of its regulators, IKKα/β, and their target IκBα, in the AhR-deficient A549 cells. In line with this, when we mimicked the exposure to a complex mixture of airborne pollutants, using an organic extract of reference diesel exhaust particle mixture, an exacerbated inflammatory response was observed in the AhR-deficient cells, as compared with wild-type A549 cells. Together, the present results indicate that the AhR may act as a negative regulator of the inflammatory response in the A549 model, via a direct modulation of NF-κB signaling. Its role(s) in the control of inflammation within the lung alveoli exposed to airborne pollutants, especially those which simultaneously activate the AhR, thus deserve further attention.

1 December 2010 in Food and Chemical Toxicology
Verified
Journal Article
Closed access
Gerardo Vázquez-GómezGerardo Vázquez-Gómez
Gerardo Vázquez-Gómez
ASA. Sánchez-Santos
A. Sánchez-Santos
JVJ. Vázquez-Medrano
J. Vázquez-Medrano
RQR. Quintanar-Zúñiga
R. Quintanar-Zúñiga
AMA.C. Monsalvo-Reyes
A.C. Monsalvo-Reyes
MHM.E. Heres-Pulido
M.E. Heres-Pulido

15 March 2019 in Oncology Letters
Verified
Journal Article
Open access
PDF file
MQManuel Nolasco Quiroga
Manuel Nolasco Quiroga
IAIsabel Alvarado‑Cabrero
Isabel Alvarado‑Cabrero
LRLeticia Rocha‑Zavaleta
Leticia Rocha‑Zavaleta
DADiego Arenas‑Aranda
Diego Arenas‑Aranda
MRMarisol Rosas‑Díaz
Marisol Rosas‑Díaz
FSFabio Salamanca‑Gómez
Fabio Salamanca‑Gómez
Focal adhesion kinase (FAK) is a non‑receptor tyrosine kinase that is expressed in most human cell types (example: Epithelial cells, fibroblasts and endothelial), it serves a key role in the control of cell survival, proliferation and motility. The abnormal expression of FAK has been associated with poor prognosis in cancer, including ovarian cancer. However, although FAK isoforms with specific molecular and functional properties have been characterized, there are a limited number of published studies that examine FAK isoforms in ovarian cancer. The aim of the present study was to analyze the expression level of FAK and its isoforms in ovarian cancer. The expression of FAK kinase and focal adhesion targeting (FAT) domains was determined with immunohistochemistry in healthy ovary, and serous and mucinous cystadenoma, borderline tumor and carcinoma samples. Additionally, the expression of FAK and its isoforms were investigated in three ovarian cancer‑derived cell lines with western blotting and reverse transcription‑semi‑quantitative polymerase chain reaction. An increased expression of FAK kinase domain was determined in serous tumor samples and was associated with advancement of the lesion. FAK kinase domain expression was moderate‑to‑low in mucinous tumor samples. The expression of the FAK FAT domain in tumor samples was reduced, compared with healthy ovary samples; however, the FAT domain was localized to the cellular nucleus. Expression of alternative transcripts FAK0, FAK28,6 and FAK28 was determined in all three cell lines investigated. In conclusion, FAK kinase and FAT domains are differentially expressed among ovarian tumor types. These results indicated the presence of at least two isoforms of FAK (FAK and the putative FAK‑related non‑kinase) in tumor tissue, which is supported by the cells producing at least three FAK alternative transcripts. These results may support the use of FAK and its isoforms as biomarkers for ovarian cancer.

1 January 2016 in TIP Revista Especializada en Ciencias Químico-Biológicas
Verified
Journal Article
Open access
Gerardo Vázquez-GómezGerardo Vázquez-Gómez
Gerardo Vázquez-Gómez
JRJulieta Rubio-Lightbourn
Julieta Rubio-Lightbourn
JEJavier J. Espinosa-Aguirre
Javier J. Espinosa-Aguirre
RESUMENEl benzo[a]pireno (b[a]p), es un hidrocarburo aromático policíclico (PAH) producto de combustiones incompletas de materia orgánica. Es considerado como carcinógeno debido a que los metabolitos derivados de su biotransformación, como el benzo [a] pireno diol epóxido (b[a]pDE), tienen propiedades mutagénicas y carcinogénicas. El b[a]p es metabolizado por las enzimas citocromos P450 1A1 (CYP1A1) y el citocromo P450 1B1 (CYP1B1) cuya expresión es inducida por la vía de señalización del receptor de hidrocarburos de arilo (AhR). Algunos estudios sugieren que el AhR es capaz de modular otros procesos celulares, además de la desintoxicación de xenobióticos como el desarrollo, diferenciación, proliferación, respuesta inmune, promoción del cáncer y apoptosis. Esto mediante la modulación de vías de señalización mediadas por proteínas cinasas como la del receptor del factor de crecimiento epidermal (EGFR, por sus siglas en inglés). Sin embargo, no es clara la función del AhR en estos procesos ni cómo el AhR es capaz de interactuar con otras vías de señalización. Las alteraciones celulares inducidas por b[a]p son complejas y pueden estar mediadas por más de una vía de señalización y la activación de múltiples genes, por lo que es esencial saber qué vías están involucradas en el metabolismo de los PAH para una mejor comprensión de las bases moleculares de enfermedades como el cáncer.ABSTRACTBenzo[a]pyrene (b[a]p), is a polycyclic aromatic hydrocarbon (PAH) product of incomplete combustion of organic matter. B[a]p is considered as a carcinogen due to the mutagenic and carcinogenic properties of its biotransformation derivatives, such as benzo[a]pyrene diol epoxide (b[a]pDE). B[a]p is metabolized by cytochrome P450 enzymes 1A1 (CYP1A1) and 1B1 (CYP1B1), whose expression is regulated by the aryl hydrocarbon receptor (AhR) signaling pathway. Studies suggest that AhR is involved in the regulation of other cellular processes, in addition to detoxification of xenobiotics, such as development, differentiation, proliferation, immune response, cancer development, and apoptosis, by modulating signaling pathways mediated by protein kinases such as the epidermal growth factor (EGFR). However it is not clear the role of AhR in these processes nor the mechanisms of AhR interaction with other signaling pathways. Cellular changes induced by b[a]p are complex and may be mediated by more than one signaling pathway and by the activation of multiple genes, so it is essential to know which pathways are involved in the metabolism of PAHs for a better understanding of the molecular basis of diseases such as cancer